Investors & Media International Stem Cell Corporation Signs Agreement Including Certain Terms for a Definitive License Agreement With Rohto Pharmaceutical Co., Ltd. of Japan International Stem Cell Corporation Completes Important Study in Parkinson's Disease Program International Stem Cell Corporation to Present at BIO 2014 International Stem Cell Corporation Announces Positive R&D and Business Results for First Quarter 2014 International Stem Cell Corporation to Host First Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Wednesday, May 14, 2014 International Stem Cell Corporation Announces Positive Parkinson's Disease Data International Stem Cell Corporation to Provide an Update on Its Parkinson's Disease Program at the 66th American Academy of Neurology Annual Meeting Lifeline Skin Care Expands Into Latin America's Second Largest Market International Stem Cell Corporation Announces 2013 Fourth Quarter and Year-End Results International Stem Cell Corporation to Host Full-Year 2013 Business Update and Financial Results Conference Call Wednesday, March 19, 2014 7 8 9 10 11 12 13 14 15 16 17 << < > >>
